Bridgewater Bancshares is the holding company for Bridgewater Bank, which offers banking products in the U.S., while Prothena develops therapies there.
4 reports, 3 independent
Updated Jun 28
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bridgewater Bancshares is the holding company for Bridgewater Bank, which offers banking products in the U.S., while Prothena develops therapies there.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Bridgewater Bank's structure and Prothena's US therapy development are reported.1 source
Bridgewater Bancshares reported financial results and sold securities acquired in an FMCB acquisition.1 source
Keep exploring
The entities involved
-
Bridgewater Bank
Nothing else this week.
-
Prothena (Ireland)
company in Dublin, Ireland
Nothing else this week.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- Simply Wall St.Discover Bridgewater Bancshares And Two Other Leading Growth Stocks With High Insider Ownership As the U.S. stock market navigates a complex landscape of fluctuating earnings reports and tariff devel
- Business WireBridgewater Bancshares, Inc. Announces Second Quarter 2025 Financial Results Second Quarter 2025 Highlights Net income of $11.5 million, or $0.38 per diluted common share; adjusted net income of $11.
- Unknown outlet